Portfolio company
Cartography
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This precision immunotherapy company develops targeted cancer therapies and an antigen atlas for medical researchers to identify cell-specific treatment targets.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
Haptena Therapeutics
This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Noetik
This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
Graph Therapeutics
This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.
Celsius Therapeutics
The company develops precision medicines for patients with autoimmune diseases and cancer by using single-cell genomic sequencing and machine learning to identify drug targets.
